1535 related articles for article (PubMed ID: 28030842)
1. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma.
Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X
Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
5. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
Ye X; Zhang J; Lu R; Zhou G
Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
[TBL] [Abstract][Full Text] [Related]
6. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
8. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY
J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
[TBL] [Abstract][Full Text] [Related]
11. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma.
Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M
Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
15. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
16. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
17. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
[TBL] [Abstract][Full Text] [Related]
19. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
20. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
